Discovery suggests potential treatment for regenerating nerve tissue after stroke

Researchers at the University of Minnesota Medical School have discovered a new population of cells in human umbilical cord blood that have properties of primitive stem cells.

Umbilical cord blood is generally known to contain hematopoietic stem cells that can only produce cells found in blood. The new findings, however, identify a small population of cord blood cells with the characteristics of more primitive stem cells that have the potential to produce a greater variety of cell types.

"We are excited by this discovery because it provides additional insight into how stem cells can restore function in the brain after injury," said Walter Low, Ph.D., senior investigator of the study, and professor of Neurosurgery and the Stem Cell Institute at the University of Minnesota.

This research was published in the latest issue of the journal Stem Cells and Development.

Transplantation of these human cord blood stem cells into laboratory rodents with experimental strokes resulted in significant reductions in the size of brain lesion, and improved these animals' use of their limbs.

Some of the transplanted stem cells developed into "neuron-like" cells that are typically found in the brain. In addition, the transplanted cells also induced an unanticipated reorganization of host nerve fibers within the brain, which may explain why the rats regained function, Low said.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Edoxaban proves effective in preventing blood clots, stroke after heart valve surgery